rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2011-6-13
|
pubmed:abstractText |
A series of novel alkyltriazole tagged pyrido[2,3-d]pyrimidine derivatives 5 and 6 was prepared starting from 2,3-active functional pyridine 1via cyclization, propargylation followed by reaction with alkyl or perfluoroalkyl azides under Sharpless conditions. All the compounds 5 and 6 were screened for anticancer activity against three cancer cell lines such as U(937), THP-1 and Colo205. The promising compounds 5b and 5e have been identified.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1768-3254
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Masson SAS. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3462-8
|
pubmed:meshHeading |
pubmed-meshheading:21632155-Alkylation,
pubmed-meshheading:21632155-Antineoplastic Agents,
pubmed-meshheading:21632155-Azides,
pubmed-meshheading:21632155-Cell Line, Tumor,
pubmed-meshheading:21632155-Cell Survival,
pubmed-meshheading:21632155-Colorectal Neoplasms,
pubmed-meshheading:21632155-Cyclization,
pubmed-meshheading:21632155-Drug Screening Assays, Antitumor,
pubmed-meshheading:21632155-Humans,
pubmed-meshheading:21632155-Inhibitory Concentration 50,
pubmed-meshheading:21632155-Leukemia, Monocytic, Acute,
pubmed-meshheading:21632155-Lymphoma,
pubmed-meshheading:21632155-Pyrimidines,
pubmed-meshheading:21632155-Structure-Activity Relationship,
pubmed-meshheading:21632155-Triazoles
|
pubmed:year |
2011
|
pubmed:articleTitle |
Synthesis of novel alkyltriazole tagged pyrido[2,3-d]pyrimidine derivatives and their anticancer activity.
|
pubmed:affiliation |
Fluoroorganic Division, Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500607, India.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|